Detalhe da pesquisa
1.
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
Oncologist
; 24(10): 1375-1383, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962295
2.
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.
J Neurooncol
; 127(3): 569-79, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26847813
3.
COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
J Am Acad Dermatol
; 84(5): 1412-1415, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581187
4.
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.
Clin Cancer Res
; 30(1): 74-81, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535056
5.
Access to melanoma drugs in Spain: a cross-sectional survey.
Clin Transl Oncol
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750345
6.
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination.
J Clin Oncol
; 41(1): 75-85, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867951
7.
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry.
Clin Transl Oncol
; 25(3): 768-775, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36566266
8.
Infusion reaction to nivolumab in a metastatic melanoma patient. Safe switch to another anti-programmed death-1: a case report.
Melanoma Res
; 31(1): 88-91, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234847
9.
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
Nat Commun
; 12(1): 7008, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853302
10.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782108
11.
Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Oral Oncol
; 102: 104526, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978755
12.
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
Neuro Oncol
; 22(12): 1851-1861, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328662
13.
Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients.
Sci Rep
; 9(1): 11125, 2019 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31366977
14.
Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM).
Ann Transl Med
; 5(19): 389, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114547
15.
Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.
Medicine (Baltimore)
; 96(52): e9523, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29384960
16.
Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implications.
Lung Cancer
; 52(3): 343-7, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16574270
17.
Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study.
Oral Oncol
; 62: 54-59, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27865372
18.
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.
Melanoma Res
; 26(3): 278-83, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26958991
19.
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study.
Eur J Cancer
; 41(9): 1254-60, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15908196
20.
Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability.
Anticancer Res
; 25(6C): 4611-4, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16334151